Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 4/2015

01-12-2015

Methodological issues in human studies of endocrine disrupting chemicals

Authors: Duk-Hee Lee, David R. Jacobs Jr.

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2015

Login to get access

Abstract

Possible harm from endocrine disrupting chemicals (EDCs) in humans is speculated based on two types of evidence; 1) increasing trends of suspected diseases in ecological studies of populations and 2) findings from traditional epidemiological studies of individuals. However, ecological findings are not regarded as direct human evidence of the relation between EDCs and disease, while the evidence among epidemiological studies of individuals is often inconsistent. Thus, a criticism is that linking EDCs and health in human is naively presumed without solid evidence. However, human studies of EDCs are methodologically complex and understanding methodological issues will help to interpret findings from existing human studies and to properly design optimal human studies. The key issues are low reliability of exposure assessment of EDCs with short half-lives, EDC mixtures, possibility of non-monotonic dose–response relationships, non-existence of an unexposed group, difficulties in measuring exposure during critical periods, and interactions with established risk factors. Furthermore, EDC mixtures may affect human health through other mechanisms than traditional endocrine disruption, for example glutathione depletion or mitochondrial dysfunction. Given this complexity, the most plausible scenario in humans is that exposure to EDC mixtures leads to increasing risk of related diseases at the ecological level, but inconsistent associations would be expected in traditional epidemiological studies. Although epidemiologists have long relied on Bradford Hill’s criteria to objectively evaluate whether associations observed in epidemiology can be interpreted as causal, there are challenges to use these criteria for EDCs, particularly concerning consistency across studies and the findings of linear dose–response relationships. At the individual level, compared to EDCs with short half-lives, epidemiological studies of EDCs with long half-lives among populations with a relatively low exposure dose range of exposure can likely produce relatively more reliable results, because the measurement of EDCs with long half-lives likely represents typical long-term exposure and populations with exposure in the low range of doses are likely to have a reference group closer to non-exposure.
Literature
1.
go back to reference UNEP/WHO. State of the science of endocrine disrupting chemicals 2012. 2013. UNEP/WHO. State of the science of endocrine disrupting chemicals 2012. 2013.
2.
go back to reference Lamb JC, Boffetta P, Foster WG, et al. Critical comments on the WHO-UNEP State of the science of endocrine disrupting chemicals - 2012. Regul Toxicol Pharmacol. 2014;69:22–40.CrossRefPubMed Lamb JC, Boffetta P, Foster WG, et al. Critical comments on the WHO-UNEP State of the science of endocrine disrupting chemicals - 2012. Regul Toxicol Pharmacol. 2014;69:22–40.CrossRefPubMed
3.
go back to reference Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342.CrossRefPubMedPubMedCentral Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342.CrossRefPubMedPubMedCentral
4.
go back to reference Barouki R, Gluckman PD, Grandjean P, et al. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012;11:42.CrossRefPubMedPubMedCentral Barouki R, Gluckman PD, Grandjean P, et al. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012;11:42.CrossRefPubMedPubMedCentral
5.
go back to reference Dietrich D, von Aulock S, Marquardt HW, et al. Open letter to the European Commission: scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles. Arch Toxicol. 2013;87:1739–41.CrossRefPubMed Dietrich D, von Aulock S, Marquardt HW, et al. Open letter to the European Commission: scientifically unfounded precaution drives European Commission’s recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles. Arch Toxicol. 2013;87:1739–41.CrossRefPubMed
6.
go back to reference Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004;199:142–50.CrossRefPubMed Newbold RR. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004;199:142–50.CrossRefPubMed
7.
8.
go back to reference Li Z, Romanoff LC, Lewin MD, et al. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expo Sci Environ Epidemiol. 2010;20:526–35.CrossRefPubMedPubMedCentral Li Z, Romanoff LC, Lewin MD, et al. Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void sampling. J Expo Sci Environ Epidemiol. 2010;20:526–35.CrossRefPubMedPubMedCentral
9.
go back to reference Preau Jr JL, Wong LY, Silva MJ, et al. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect. 2010;118:1748–54.CrossRefPubMedPubMedCentral Preau Jr JL, Wong LY, Silva MJ, et al. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ Health Perspect. 2010;118:1748–54.CrossRefPubMedPubMedCentral
10.
go back to reference Ye X, Wong LY, Bishop AM, et al. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect. 2011;119:983–8.CrossRefPubMedPubMedCentral Ye X, Wong LY, Bishop AM, et al. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect. 2011;119:983–8.CrossRefPubMedPubMedCentral
11.
go back to reference Kissel JC, Curl CL, Kedan G, et al. Comparison of organophosphorus pesticide metabolite levels in single and multiple daily urine samples collected from preschool children in Washington State. J Expo Anal Environ Epidemiol. 2005;15:164–71.CrossRefPubMed Kissel JC, Curl CL, Kedan G, et al. Comparison of organophosphorus pesticide metabolite levels in single and multiple daily urine samples collected from preschool children in Washington State. J Expo Anal Environ Epidemiol. 2005;15:164–71.CrossRefPubMed
12.
go back to reference Scher DP, Alexander BH, Adgate JL, et al. Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children. J Expo Sci Environ Epidemiol. 2007;17:350–7.CrossRefPubMed Scher DP, Alexander BH, Adgate JL, et al. Agreement of pesticide biomarkers between morning void and 24-h urine samples from farmers and their children. J Expo Sci Environ Epidemiol. 2007;17:350–7.CrossRefPubMed
13.
go back to reference Vrijheid M, Slama R, Robinson O, et al. The human early-life exposome (HELIX): project rationale and design. Environ Health Perspect. 2014;122:535–44.PubMedPubMedCentral Vrijheid M, Slama R, Robinson O, et al. The human early-life exposome (HELIX): project rationale and design. Environ Health Perspect. 2014;122:535–44.PubMedPubMedCentral
15.
go back to reference Silva E, Rajapakse N, Kortenkamp A. Something from “nothing”--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol. 2002;36:1751–6.CrossRefPubMed Silva E, Rajapakse N, Kortenkamp A. Something from “nothing”--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects. Environ Sci Technol. 2002;36:1751–6.CrossRefPubMed
16.
go back to reference Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect. 2007;115 Suppl 1:98–105.CrossRefPubMedPubMedCentral Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect. 2007;115 Suppl 1:98–105.CrossRefPubMedPubMedCentral
17.
go back to reference Kretschmer XC, Baldwin WS. CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact. 2005;155:111–28.CrossRefPubMed Kretschmer XC, Baldwin WS. CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact. 2005;155:111–28.CrossRefPubMed
18.
go back to reference Kortenkamp A. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. Int J Androl. 2008;31:233–40.CrossRefPubMed Kortenkamp A. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. Int J Androl. 2008;31:233–40.CrossRefPubMed
19.
go back to reference Lioy PJ, Rappaport SM. Exposure science and the exposome: an opportunity for coherence in the environmental health sciences. Environ Health Perspect. 2011;119:A466–7.CrossRefPubMedPubMedCentral Lioy PJ, Rappaport SM. Exposure science and the exposome: an opportunity for coherence in the environmental health sciences. Environ Health Perspect. 2011;119:A466–7.CrossRefPubMedPubMedCentral
20.
go back to reference Taylor KW, Novak RF, Anderson HA, et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect. 2013;121:774–83.CrossRefPubMedPubMedCentral Taylor KW, Novak RF, Anderson HA, et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect. 2013;121:774–83.CrossRefPubMedPubMedCentral
21.
go back to reference Wu H, Bertrand KA, Choi AL, et al. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses’ health study and meta-analysis. Environ Health Perspect. 2013;121:153–61.PubMedPubMedCentral Wu H, Bertrand KA, Choi AL, et al. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses’ health study and meta-analysis. Environ Health Perspect. 2013;121:153–61.PubMedPubMedCentral
22.
go back to reference Beausoleil C, Ormsby JN, Gies A, et al. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere. 2013;93:847–56.CrossRefPubMed Beausoleil C, Ormsby JN, Gies A, et al. Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere. 2013;93:847–56.CrossRefPubMed
23.
go back to reference Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33:378–455.CrossRefPubMedPubMedCentral Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33:378–455.CrossRefPubMedPubMedCentral
24.
go back to reference Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol. 2012;64:130–3.CrossRefPubMed Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol. 2012;64:130–3.CrossRefPubMed
25.
go back to reference Calabrese EJ. Hormetic dose–response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol. 2005;35:89–295.CrossRefPubMed Calabrese EJ. Hormetic dose–response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol. 2005;35:89–295.CrossRefPubMed
26.
go back to reference Kendig EL, Le HH, Belcher SM. Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol. 2010;29:235–46.CrossRefPubMed Kendig EL, Le HH, Belcher SM. Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol. 2010;29:235–46.CrossRefPubMed
27.
go back to reference Bergman A, Becher G, Blumberg B, et al. Manufacturing doubt about endocrine disrupter science - A rebuttal of industry-sponsored critical comments on the UNEP/WHO report State of the Science of Endocrine Disrupting Chemicals 2012. Regul Toxicol Pharmacol. 2015. Bergman A, Becher G, Blumberg B, et al. Manufacturing doubt about endocrine disrupter science - A rebuttal of industry-sponsored critical comments on the UNEP/WHO report State of the Science of Endocrine Disrupting Chemicals 2012. Regul Toxicol Pharmacol. 2015.
28.
go back to reference Lee DH, Porta M, Jacobs Jr DR, et al. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev. 2014;35:557–601.CrossRefPubMed Lee DH, Porta M, Jacobs Jr DR, et al. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev. 2014;35:557–601.CrossRefPubMed
29.
go back to reference Golden R, Kimbrough R. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003. Crit Rev Toxicol. 2009;39:299–331.CrossRefPubMed Golden R, Kimbrough R. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003. Crit Rev Toxicol. 2009;39:299–331.CrossRefPubMed
30.
go back to reference Bergman A, Andersson AM, Becher G, et al. Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors. Environ Health. 2013;12:69.CrossRefPubMedPubMedCentral Bergman A, Andersson AM, Becher G, et al. Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors. Environ Health. 2013;12:69.CrossRefPubMedPubMedCentral
31.
go back to reference Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14:1847–50.CrossRefPubMed Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14:1847–50.CrossRefPubMed
32.
go back to reference Dijk DJ, Lockley SW. Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol (1985). 2002;92:852–62.CrossRef Dijk DJ, Lockley SW. Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol (1985). 2002;92:852–62.CrossRef
33.
go back to reference Sheehan DM. No-threshold dose–response curves for nongenotoxic chemicals: findings and applications for risk assessment. Environ Res. 2006;100:93–9.CrossRefPubMed Sheehan DM. No-threshold dose–response curves for nongenotoxic chemicals: findings and applications for risk assessment. Environ Res. 2006;100:93–9.CrossRefPubMed
34.
go back to reference Beier EE, Inzana JA, Sheu TJ, et al. Effects of combined exposure to lead and high-fat diet on bone quality in Juvenile male mice. Environ Health Perspect. 2015;123:935–43.CrossRefPubMedPubMedCentral Beier EE, Inzana JA, Sheu TJ, et al. Effects of combined exposure to lead and high-fat diet on bone quality in Juvenile male mice. Environ Health Perspect. 2015;123:935–43.CrossRefPubMedPubMedCentral
35.
go back to reference Wahlang B, Falkner KC, Gregory B, et al. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem. 2013;24:1587–95.CrossRefPubMedPubMedCentral Wahlang B, Falkner KC, Gregory B, et al. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem. 2013;24:1587–95.CrossRefPubMedPubMedCentral
36.
go back to reference Wei J, Lin Y, Li Y, et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology. 2011;152:3049–61.CrossRefPubMed Wei J, Lin Y, Li Y, et al. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology. 2011;152:3049–61.CrossRefPubMed
37.
go back to reference Lim JS, Son HK, Park SK, et al. Inverse associations between long-term weight change and serum concentrations of persistent organic pollutants. Int J Obes (Lond). 2011;35:744–7.CrossRef Lim JS, Son HK, Park SK, et al. Inverse associations between long-term weight change and serum concentrations of persistent organic pollutants. Int J Obes (Lond). 2011;35:744–7.CrossRef
38.
go back to reference Lind L, Lind PM. Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J Intern Med. 2012;271:537–53.CrossRefPubMed Lind L, Lind PM. Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease? J Intern Med. 2012;271:537–53.CrossRefPubMed
39.
go back to reference Robison AK, Stancel GM. The estrogenic activity of DDT: correlation of estrogenic effect with nuclear level of estrogen receptor. Life Sci. 1982;31:2479–84.CrossRefPubMed Robison AK, Stancel GM. The estrogenic activity of DDT: correlation of estrogenic effect with nuclear level of estrogen receptor. Life Sci. 1982;31:2479–84.CrossRefPubMed
40.
go back to reference Mills LJ, Gutjahr-Gobell RE, Haebler RA, et al. Effects of estrogenic (o, p’-DDT; octylphenol) and anti-androgenic (p, p’-DDE) chemicals on indicators of endocrine status in juvenile male summer flounder (Paralichthys dentatus). Aquat Toxicol. 2001;52:157–76.CrossRefPubMed Mills LJ, Gutjahr-Gobell RE, Haebler RA, et al. Effects of estrogenic (o, p’-DDT; octylphenol) and anti-androgenic (p, p’-DDE) chemicals on indicators of endocrine status in juvenile male summer flounder (Paralichthys dentatus). Aquat Toxicol. 2001;52:157–76.CrossRefPubMed
41.
go back to reference Jansen HT, Cooke PS, Porcelli J, et al. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol. 1993;7:237–48.CrossRefPubMed Jansen HT, Cooke PS, Porcelli J, et al. Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies. Reprod Toxicol. 1993;7:237–48.CrossRefPubMed
42.
go back to reference Ma R, Sassoon DA. PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect. 2006;114:898–904.CrossRefPubMedPubMedCentral Ma R, Sassoon DA. PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect. 2006;114:898–904.CrossRefPubMedPubMedCentral
43.
go back to reference Giera S, Bansal R, Ortiz-Toro TM, et al. Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development. Endocrinology. 2011;152:2909–19.CrossRefPubMedPubMedCentral Giera S, Bansal R, Ortiz-Toro TM, et al. Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development. Endocrinology. 2011;152:2909–19.CrossRefPubMedPubMedCentral
44.
45.
go back to reference Lee DH, Jacobs Jr DR. Hormesis and public health: can glutathione depletion and mitochondrial dysfunction due to very low-dose chronic exposure to persistent organic pollutants be mitigated? J Epidemiol Community Health. 2015;69:294–300.CrossRefPubMed Lee DH, Jacobs Jr DR. Hormesis and public health: can glutathione depletion and mitochondrial dysfunction due to very low-dose chronic exposure to persistent organic pollutants be mitigated? J Epidemiol Community Health. 2015;69:294–300.CrossRefPubMed
46.
go back to reference Zoeller RT, Bergman A, Becher G, et al. A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ Health. 2015;14:118.CrossRef Zoeller RT, Bergman A, Becher G, et al. A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ Health. 2015;14:118.CrossRef
Metadata
Title
Methodological issues in human studies of endocrine disrupting chemicals
Authors
Duk-Hee Lee
David R. Jacobs Jr.
Publication date
01-12-2015
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 4/2015
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-016-9340-9

Other articles of this Issue 4/2015

Reviews in Endocrine and Metabolic Disorders 4/2015 Go to the issue

EditorialNotes

Preface

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine